A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy
Top Cited Papers
- 1 December 2013
- journal article
- Published by Elsevier BV in European Urology
- Vol. 64 (6), 895-902
- https://doi.org/10.1016/j.eururo.2013.03.033
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Contemporary Evaluation of the National Comprehensive Cancer Network Prostate Cancer Risk Classification SystemUrology, 2012
- Radical Prostatectomy versus Observation for Localized Prostate CancerThe New England Journal of Medicine, 2012
- Variation in Use of Androgen Suppression With External-Beam Radiotherapy for Nonmetastatic Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2012
- National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate CancerAnnals of Internal Medicine, 2012
- The Relationship Between Clinical Benefit and Receipt of Curative Therapy for Prostate CancerJAMA Internal Medicine, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up StudyJNCI Journal of the National Cancer Institute, 2010
- Time Trends and Local Variation in Primary Treatment of Localized Prostate CancerJournal of Clinical Oncology, 2010
- Prostate CancerJournal of the National Comprehensive Cancer Network, 2010
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?Journal of Clinical Oncology, 2009